X0202 3 2007-05-11 0 0001066833 DOV PHARMACEUTICAL INC DOVP 0001278736 POLYGON GLOBAL OPPORTUNITIES MASTER FUND C/O POLYGON INVESTMENT PARTNERS LLP 10 DUKE OF YORK SQUARE LONDON SW3 4LY UNITED KINGDOM 0 0 1 0 0001308513 Polygon Investment Partners LLP C/O POLYGON INVESTMENT PARTNERS LLP 10 DUKE OF YORK SQUARE LONDON SW3 4LY UNITED KINGDOM 0 0 1 0 0001308514 Polygon Investment Partners LP C/O POLYGON INVESTMENT PARTNERS LLP 10 DUKE OF YORK SQUARE LONDON SW3 4LY UNITED KINGDOM 0 0 1 0 0001388444 Polygon Investment Partners HK LTD C/O POLYGON INVESTMENT PARTNERS LLP 10 DUKE OF YORK SQUARE LONDON SW3 4LY UNITED KINGDOM 0 0 1 0 0001308098 Polygon Investments Ltd. C/O POLYGON INVESTMENT PARTNERS LLP 10 DUKE OF YORK SQUARE LONDON SW3 4LY UNITED KINGDOM 0 0 1 0 0001400002 Polygon Investment Management LTD C/O POLYGON INVESTMENT PARTNERS LLP 10 DUKE OF YORK SQUARE LONDON SW3 4LY UNITED KINGDOM 0 0 1 0 0001400001 Polygon Investment Partners GP, LLC C/O POLYGON INVESTMENT PARTNERS LLP 10 DUKE OF YORK SQUARE LONDON SW3 4LY UNITED KINGDOM 0 0 1 0 0001399998 Reade E. Griffith C/O POLYGON INVESTMENT PARTNERS LLP 10 DUKE OF YORK SQUARE LONDON SW3 4LY UNITED KINGDOM 0 0 1 0 0001399994 Alexander E. Jackson C/O POLYGON INVESTMENT PARTNERS LLP 10 DUKE OF YORK SQUARE LONDON SW3 4LY UNITED KINGDOM 0 0 1 0 0001399996 Patrick G. G. Dear C/O POLYGON INVESTMENT PARTNERS LLP 10 DUKE OF YORK SQUARE LONDON SW3 4LY UNITED KINGDOM 0 0 1 0 Series C Convertible Preferred Stock Common Stock 12225672 D Series D Convertible Preferred Stock Common Stock 19102612 D The Series C Convertible Preferred Stock is convertible into common stock at any time, at the holders' election, between May 11, 2007 and June 10, 2007 at a conversion rate of 191.02612143 shares of common stock for one share of Series C Convertible Preferred Stock. All shares of Series C Convertible Preferred Stock not converted on June 10, 2007 shall be automatically converted to common stock. The Series D Convertible Preferred Stock is convertible into common stock at any time after May 11, 2007, to the extent that the Reporting Persons would not beneficially own shares of capital stock having in excess of 9.99% of the voting power of Dov immediately after giving effect to such conversion. The Series D Convertible Preferred Stock has no expiration date and is convertible into common stock at a conversion rate of 191.02612143 shares of common stock for one share of Series D Convertible Preferred Stock. This Form 3 is filed on behalf of Polygon Global Opportunities Master Fund, Polygon Investments Ltd., Polygon Investment Management Limited, Polygon Investment Partners LLP, Polygon Investment Partners LP, Polygon Investment Partners HK Limited, Polygon Investment Partners GP, LLC, Mr. Reade E. Griffith, Mr. Alexander E. Jackson and Mr. Patrick G. G. Dear. POLYGON GLOBAL OPPORTUNITIES MASTER FUND By: Polygon Investment Partners LLP, its investment manager By: /s/ Patrick G. G. Dear, Principal 2007-05-21 POLYGON INVESTMENT MANAGEMENT LIMITED By: /s/ Patrick G. G. Dear, Principal 2007-05-21 POLYGON INVESTMENTS LTD. By: /s/ Patrick G. G. Dear, Principal 2007-05-21 POLYGON INVESTMENT PARTNERS LLP By: /s/ Patrick G. G. Dear, Principal 2007-05-21 POLYGON INVESTMENT PARTNERS LP By: /s/ Patrick G. G. Dear, Principal 2007-05-21 POLYGON INVESTMENT PARTNERS HK LIMITED By: /s/ Patrick G. G. Dear, Principal 2007-05-21 POLYGON INVESTMENT PARTNERS GP, LLC By: /s/ Patrick G. G. Dear, Principal 2007-05-21 /s/ Reade E. Griffith 2007-05-21 /s/ Alexander E. Jackson 2007-05-21 /s/ Patrick G G. Dear 2007-05-21